Other Species / Isoforms
  NUSAP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
PSLEELDsLKYSDLQ
0 1
NUSAP1 (human) PSLEELDsLKYSDLQ S11-p
NUSAP1 iso2 (human) PSLEELDSLKYSDLQ S11
NUSAP1 (mouse) PSAEELDSFKYSDLQ S11
NUSAP1 (rat) PSAEELDSFKYSDLQ S11
R27
LAKSLGLRANLRAtK
0 1
NUSAP1 (human) LAKSLGLRANLRAtK R27
NUSAP1 iso2 (human) LAKSLGLRANLRATK R27
NUSAP1 (mouse) LAKRLGLrANMKADK R27-m1
NUSAP1 (rat) LAKRLGLRANLRADK R27
T33-p
LRANLRAtKLLKALK
0 1
NUSAP1 (human) LRANLRAtKLLKALK T33-p
NUSAP1 iso2 (human) LRANLRATKLLKALK T33
NUSAP1 (mouse) LrANMKADKLLKALK D33
NUSAP1 (rat) LRANLRADKLLRALK D33
S101-p
TVRVDPDsQQNHsEI
0 2
NUSAP1 (human) TVRVDPDsQQNHsEI S101-p
NUSAP1 iso2 (human) TVRVDPDSQQNHSEI S101
NUSAP1 (mouse) TIHGIPTSQTLLQDH S102
NUSAP1 (rat) TIHGIPTSQDHMEMK S102
S106-p
PDsQQNHsEIKISNP
0 1
NUSAP1 (human) PDsQQNHsEIKISNP S106-p
NUSAP1 iso2 (human) PDSQQNHSEIKISNP S106
NUSAP1 (mouse) QTLLQDHLEMKGTDS L110
NUSAP1 (rat) IPTSQDHMEMKRRDs M106
P113
sEIKISNPTEFQNHE
0 3
NUSAP1 (human) sEIKISNPTEFQNHE P113
NUSAP1 iso2 (human) SEIKISNPTEFQNHE P113
NUSAP1 (mouse) LEMKGTDSSNFQNQE S117
NUSAP1 (rat) MEMKRRDsTtFQNQE S113-p
E115
IKISNPTEFQNHEKQ
0 1
NUSAP1 (human) IKISNPTEFQNHEKQ E115
NUSAP1 iso2 (human) IKISNPTEFQNHEKQ E115
NUSAP1 (mouse) MKGTDSSNFQNQENQ N119
NUSAP1 (rat) MKRRDsTtFQNQENQ T115-p
S124-p
QNHEKQEsQDLRATA
Upstream
Downstream
1 8
Effects on Biological Processes:
  • cell cycle regulation
Putative in vivo kinases:
  • ATM (human)
Treatment
  • BI2536
  • caffeine
  • nocodazole
  • siRNA
NUSAP1 (human) QNHEKQEsQDLRATA S124-p
NUSAP1 iso2 (human) QNHEKQESQDLRATA S124
NUSAP1 (mouse) QNQENQENQDPRDTA N128
NUSAP1 (rat) TtFQNQENQDLRATE N121
S135-p
RATAKVPsPPDEHQE
Upstream
0 18
Treatment
  • EGF
  • nocodazole
NUSAP1 (human) RATAKVPsPPDEHQE S135-p
NUSAP1 iso2 (human) RATAKVPSPPDEHQE S135
NUSAP1 (mouse) RDTAEVPSLPEQRPE S139
NUSAP1 (rat) RATEKVPSLPEQRPE S132
S148
QEAENAVSsGNRDsK
0 1
NUSAP1 (human) QEAENAVSsGNRDsK S148
NUSAP1 iso2 (human) QEAENAVSSGNRDSK S148
NUSAP1 (mouse) PEDGNAAssGEGEVN S152-p
NUSAP1 (rat) PEDGNAASSEEGKIN S145
S149-p
EAENAVSsGNRDsKV
0 4
NUSAP1 (human) EAENAVSsGNRDsKV S149-p
NUSAP1 iso2 (human) EAENAVSSGNRDSKV S149
NUSAP1 (mouse) EDGNAAssGEGEVND S153-p
NUSAP1 (rat) EDGNAASSEEGKIND S146
S154-p
VSsGNRDsKVPsEGK
0 1
NUSAP1 (human) VSsGNRDsKVPsEGK S154-p
NUSAP1 iso2 (human) VSSGNRDSKVPSEGK S154
NUSAP1 (mouse) AssGEGEVNDIKDSK V158
NUSAP1 (rat) ASSEEGKINDKKGPL I151
S158-p
NRDsKVPsEGKKSLy
0 2
NUSAP1 (human) NRDsKVPsEGKKSLy S158-p
NUSAP1 iso2 (human) NRDSKVPSEGKKSLY S158
NUSAP1 (mouse) EVNDIKDSKKPLEKR S164
NUSAP1 (rat) gap -
Y165-p
sEGKKSLyTDEssKP
0 11
NUSAP1 (human) sEGKKSLyTDEssKP Y165-p
NUSAP1 iso2 (human) SEGKKSLYTDESSKP Y165
NUSAP1 (mouse) PLEKRSLCTDEFSKL C174
NUSAP1 (rat) PLEKRSLCTDGFSKL C164
S169-p
KSLyTDEssKPGKNK
0 1
NUSAP1 (human) KSLyTDEssKPGKNK S169-p
NUSAP1 iso2 (human) KSLYTDESSKPGKNK S169
NUSAP1 (mouse) RSLCTDEFSKLGNNK F178
NUSAP1 (rat) RSLCTDGFSKLGNSK F168
S170-p
SLyTDEssKPGKNKR
0 2
NUSAP1 (human) SLyTDEssKPGKNKR S170-p
NUSAP1 iso2 (human) SLYTDESSKPGKNKR S170
NUSAP1 (mouse) SLCTDEFSKLGNNKR S179
NUSAP1 (rat) SLCTDGFSKLGNSKR S169
T181-p
KNKRTAIttPNFkkL
0 3
NUSAP1 (human) KNKRTAIttPNFkkL T181-p
NUSAP1 iso2 (human) KNKRTAITTPNFKKL T181
NUSAP1 (mouse) NNKRTSATTPNFKKL T190
NUSAP1 (rat) NSKRISATTPNFKRL T180
T182-p
NKRTAIttPNFkkLH
Upstream
0 39
Treatment
  • nocodazole
NUSAP1 (human) NKRTAIttPNFkkLH T182-p
NUSAP1 iso2 (human) NKRTAITTPNFKKLH T182
NUSAP1 (mouse) NKRTSATTPNFKKLH T191
NUSAP1 (rat) SKRISATTPNFKRLH T181
K186-m1
AIttPNFkkLHEAHF
0 1
NUSAP1 (human) AIttPNFkkLHEAHF K186-m1
NUSAP1 iso2 (human) AITTPNFKKLHEAHF K186
NUSAP1 (mouse) SATTPNFKKLHEARF K195
NUSAP1 (rat) SATTPNFKRLHEAHF K185
K187-ub
IttPNFkkLHEAHFK
0 1
NUSAP1 (human) IttPNFkkLHEAHFK K187-ub
NUSAP1 iso2 (human) ITTPNFKKLHEAHFK K187
NUSAP1 (mouse) ATTPNFKKLHEARFK K196
NUSAP1 (rat) ATTPNFKRLHEAHFK R186
S215-p
KHFEEHNsMNELKQQ
Upstream
0 2
Treatment
  • nocodazole
NUSAP1 (human) KHFEEHNsMNELKQQ S215-p
NUSAP1 iso2 (human) KHFEEHNSMNELKQP S215
NUSAP1 (mouse) KHLKEHSSLNELKLD S224
NUSAP1 (rat) KHFKEHDSLNELKLD S214
T231-p
INKGGVRtPVPPRGR
0 4
NUSAP1 (human) INKGGVRtPVPPRGR T231-p
NUSAP1 iso2 (human) INKGGVRTPVPPRGR T230
NUSAP1 (mouse) LDKKGIVTPVPPrGR T237
NUSAP1 (rat) LKLDKKVTPVPPRGR T225
R236
VRtPVPPRGRLsVAs
0 1
NUSAP1 (human) VRtPVPPRGRLsVAs R236
NUSAP1 iso2 (human) VRTPVPPRGRLSVAS R235
NUSAP1 (mouse) IVTPVPPrGRLSVPC R242-m1
NUSAP1 (rat) KVTPVPPRGRLSVLC R230
S240-p
VPPRGRLsVAstPIs
Upstream
0 36
Kinase, in vitro:
  • AurB (human)
Putative in vivo kinases:
  • AurA (human)
Regulatory protein:
  • OGT (human)
Treatment
  • nocodazole
NUSAP1 (human) VPPRGRLsVAstPIs S240-p
NUSAP1 iso2 (human) VPPRGRLSVASTPIS S239
NUSAP1 (mouse) VPPrGRLSVPCTPAR S246
NUSAP1 (rat) VPPRGRLSVLCTPAR S234
S243-p
RGRLsVAstPIsQRR
0 5
NUSAP1 (human) RGRLsVAstPIsQRR S243-p
NUSAP1 iso2 (human) RGRLSVASTPISQRR S242
NUSAP1 (mouse) rGRLSVPCTPARQQC C249
NUSAP1 (rat) RGRLSVLCTPARQRC C237
T244-p
GRLsVAstPIsQRRs
0 42
NUSAP1 (human) GRLsVAstPIsQRRs T244-p
NUSAP1 iso2 (human) GRLSVASTPISQRRS T243
NUSAP1 (mouse) GRLSVPCTPARQQCP T250
NUSAP1 (rat) GRLSVLCTPARQRCS T238
S247-p
sVAstPIsQRRsQGR
Upstream
0 36
Treatment
  • MLN8054
  • nocodazole
NUSAP1 (human) sVAstPIsQRRsQGR S247-p
NUSAP1 iso2 (human) SVASTPISQRRSQGR S246
NUSAP1 (mouse) SVPCTPARQQCPQGH R253
NUSAP1 (rat) SVLCTPARQRCSQGH R241
S251-p
tPIsQRRsQGRsCGP
Upstream
0 11
Treatment
  • BI2536
  • MLN8054
NUSAP1 (human) tPIsQRRsQGRsCGP S251-p
NUSAP1 iso2 (human) TPISQRRSQGRSCGP S250
NUSAP1 (mouse) TPARQQCPQGHSATK P257
NUSAP1 (rat) TPARQRCSQGHSATK S245
S255-p
QRRsQGRsCGPAsQs
0 7
NUSAP1 (human) QRRsQGRsCGPAsQs S255-p
NUSAP1 iso2 (human) QRRSQGRSCGPASQS S254
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
S260-p
GRsCGPAsQstLGLk
0 6
NUSAP1 (human) GRsCGPAsQstLGLk S260-p
NUSAP1 iso2 (human) GRSCGPASQSTLGLK S259
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
S262-p
sCGPAsQstLGLkGs
0 3
NUSAP1 (human) sCGPAsQstLGLkGs S262-p
NUSAP1 iso2 (human) SCGPASQSTLGLKGS S261
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
T263-p
CGPAsQstLGLkGsL
0 3
NUSAP1 (human) CGPAsQstLGLkGsL T263-p
NUSAP1 iso2 (human) CGPASQSTLGLKGSL T262
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
K267-m1
sQstLGLkGsLkRsA
0 1
NUSAP1 (human) sQstLGLkGsLkRsA K267-m1
NUSAP1 iso2 (human) SQSTLGLKGSLKRSA K266
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
S269-p
stLGLkGsLkRsAIs
0 13
NUSAP1 (human) stLGLkGsLkRsAIs S269-p
NUSAP1 iso2 (human) STLGLKGSLKRSAIS S268
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
K271-m1
LGLkGsLkRsAIsAA
0 1
NUSAP1 (human) LGLkGsLkRsAIsAA K271-m1
NUSAP1 iso2 (human) LGLKGSLKRSAISAA K270
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
S273-p
LkGsLkRsAIsAAkT
0 2
NUSAP1 (human) LkGsLkRsAIsAAkT S273-p
NUSAP1 iso2 (human) LKGSLKRSAISAAKT S272
NUSAP1 (mouse) gap -
NUSAP1 (rat) gap -
S276-p
sLkRsAIsAAkTGVR
Upstream
0 2
Treatment
  • nocodazole
NUSAP1 (human) sLkRsAIsAAkTGVR S276-p
NUSAP1 iso2 (human) SLKRSAISAAKTGVR S275
NUSAP1 (mouse) QQCPQGHSATKMNVR S261
NUSAP1 (rat) QRCSQGHSATKMNVR S249
K279-ub
RsAIsAAkTGVRFsA
0 1
NUSAP1 (human) RsAIsAAkTGVRFsA K279-ub
NUSAP1 iso2 (human) RSAISAAKTGVRFSA K278
NUSAP1 (mouse) under review -
NUSAP1 (rat) under review -
S285-p
AkTGVRFsAATkDNE
0 2
NUSAP1 (human) AkTGVRFsAATkDNE S285-p
NUSAP1 iso2 (human) AKTGVRFSAATKDNE S284
NUSAP1 (mouse) TKMNVRFSAATKDNE S270
NUSAP1 (rat) TKMNVRFSAATKDNE S258
K289-ac
VRFsAATkDNEHKRs
0 1
NUSAP1 (human) VRFsAATkDNEHKRs K289-ac
NUSAP1 iso2 (human) VRFSAATKDNEHKRS K288
NUSAP1 (mouse) VRFSAATKDNEHKCS K274
NUSAP1 (rat) VRFSAATKDNEHKCS K262
S296-p
kDNEHKRsLtKtPAR
0 1
NUSAP1 (human) kDNEHKRsLtKtPAR S296-p
NUSAP1 iso2 (human) KDNEHKRSLTKTPAR S295
NUSAP1 (mouse) KDNEHKCSLTKTPAR S281
NUSAP1 (rat) KDNEHKCSLTKTPAR S269
T298-p
NEHKRsLtKtPARks
0 1
NUSAP1 (human) NEHKRsLtKtPARks T298-p
NUSAP1 iso2 (human) NEHKRSLTKTPARKS T297
NUSAP1 (mouse) NEHKCSLTKTPARKs T283
NUSAP1 (rat) NEHKCSLTKTPARKS T271
T300-p
HKRsLtKtPARksAH
Upstream
Downstream
1 3
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • seliciclib
NUSAP1 (human) HKRsLtKtPARksAH T300-p
NUSAP1 iso2 (human) HKRSLTKTPARKSAH T299
NUSAP1 (mouse) HKCSLTKTPARKsPH T285
NUSAP1 (rat) HKCSLTKTPARKSPH T273
K304-ub
LtKtPARksAHVTVs
0 1
NUSAP1 (human) LtKtPARksAHVTVs K304-ub
NUSAP1 iso2 (human) LTKTPARKSAHVTVS K303
NUSAP1 (mouse) LTKTPARKsPHVTAP K289
NUSAP1 (rat) LTKTPARKSPHVTAP K277
S305-p
tKtPARksAHVTVsG
Upstream
0 4
Treatment
  • nocodazole
NUSAP1 (human) tKtPARksAHVTVsG S305-p
NUSAP1 iso2 (human) TKTPARKSAHVTVSG S304
NUSAP1 (mouse) TKTPARKsPHVTAPG S290-p
NUSAP1 (rat) TKTPARKSPHVTAPG S278
S311-p
ksAHVTVsGGtPkGE
Upstream
0 6
Treatment
  • nocodazole
NUSAP1 (human) ksAHVTVsGGtPkGE S311-p
NUSAP1 iso2 (human) KSAHVTVSGGTPKGE S310
NUSAP1 (mouse) KsPHVTAPGsASKGQ P296
NUSAP1 (rat) KSPHVTAPGSASKGQ P284
G313
AHVTVsGGtPkGEAV
0 1
NUSAP1 (human) AHVTVsGGtPkGEAV G313
NUSAP1 iso2 (human) AHVTVSGGTPKGEAV G312
NUSAP1 (mouse) PHVTAPGsASKGQAV S298-p
NUSAP1 (rat) PHVTAPGSASKGQAV S286
T314-p
HVTVsGGtPkGEAVL
Upstream
0 12
Treatment
  • nocodazole
NUSAP1 (human) HVTVsGGtPkGEAVL T314-p
NUSAP1 iso2 (human) HVTVSGGTPKGEAVL T313
NUSAP1 (mouse) HVTAPGsASKGQAVF A299
NUSAP1 (rat) HVTAPGSASKGQAVL A287
K316-ub
TVsGGtPkGEAVLGT
0 1
NUSAP1 (human) TVsGGtPkGEAVLGT K316-ub
NUSAP1 iso2 (human) TVSGGTPKGEAVLGT K315
NUSAP1 (mouse) under review -
NUSAP1 (rat) under review -
S333-p
LKTITGNsAAVItPF
0 2
NUSAP1 (human) LKTITGNsAAVItPF S333-p
NUSAP1 iso2 (human) LKTITGNSAAVITPF S332
NUSAP1 (mouse) SKATERTSIAVItPF S318
NUSAP1 (rat) LKTTERNSTAGKLKP S306
T338-p
GNsAAVItPFKLttE
Upstream
Downstream
1 14
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • seliciclib
NUSAP1 (human) GNsAAVItPFKLttE T338-p
NUSAP1 iso2 (human) GNSAAVITPFKLTTE T337
NUSAP1 (mouse) RTSIAVItPFKLMTE T323-p
NUSAP1 (rat) gap -
T343-p
VItPFKLttEAtQtP
0 1
NUSAP1 (human) VItPFKLttEAtQtP T343-p
NUSAP1 iso2 (human) VITPFKLTTEATQTP T342
NUSAP1 (mouse) VItPFKLMTEATQTP M328
NUSAP1 (rat) gap -
T344-p
ItPFKLttEAtQtPV
0 1
NUSAP1 (human) ItPFKLttEAtQtPV T344-p
NUSAP1 iso2 (human) ITPFKLTTEATQTPV T343
NUSAP1 (mouse) ItPFKLMTEATQTPS T329
NUSAP1 (rat) gap -
T347-p
FKLttEAtQtPVsNK
0 2
NUSAP1 (human) FKLttEAtQtPVsNK T347-p
NUSAP1 iso2 (human) FKLTTEATQTPVSNK T346
NUSAP1 (mouse) FKLMTEATQTPSSSK T332
NUSAP1 (rat) gap -
T349-p
LttEAtQtPVsNKkP
Upstream
0 11
Treatment
  • vemurafenib
NUSAP1 (human) LttEAtQtPVsNKkP T349-p
NUSAP1 iso2 (human) LTTEATQTPVSNKKP T348
NUSAP1 (mouse) LMTEATQTPSSSKKP T334
NUSAP1 (rat) gap -
S352-p
EAtQtPVsNKkPVFD
Upstream
0 18
Treatment
  • nocodazole
NUSAP1 (human) EAtQtPVsNKkPVFD S352-p
NUSAP1 iso2 (human) EATQTPVSNKKPVFD S351
NUSAP1 (mouse) EATQTPSSSKKPVFD S337
NUSAP1 (rat) gap -
K355-ub
QtPVsNKkPVFDLkA
0 1
NUSAP1 (human) QtPVsNKkPVFDLkA K355-ub
NUSAP1 iso2 (human) QTPVSNKKPVFDLKA K354
NUSAP1 (mouse) QTPSSSKKPVFDLKA K340
NUSAP1 (rat) under review -
K361-ub
KkPVFDLkAsLsRPL
0 1
NUSAP1 (human) KkPVFDLkAsLsRPL K361-ub
NUSAP1 iso2 (human) KKPVFDLKASLSRPL K360
NUSAP1 (mouse) KKPVFDLKASLSRPL K346
NUSAP1 (rat) under review -
S363-p
PVFDLkAsLsRPLNY
0 3
NUSAP1 (human) PVFDLkAsLsRPLNY S363-p
NUSAP1 iso2 (human) PVFDLKASLSRPLNY S362
NUSAP1 (mouse) PVFDLKASLSRPLNY S348
NUSAP1 (rat) gap -
S365-p
FDLkAsLsRPLNYEP
0 1
NUSAP1 (human) FDLkAsLsRPLNYEP S365-p
NUSAP1 iso2 (human) FDLKASLSRPLNYEP S364
NUSAP1 (mouse) FDLKASLSRPLNYKP S350
NUSAP1 (rat) gap -
K376-ub
NYEPHKGkLkPWGQS
0 1
NUSAP1 (human) NYEPHKGkLkPWGQS K376-ub
NUSAP1 iso2 (human) NYEPHKGKLKPWGQS K375
NUSAP1 (mouse) NYKPHKGKLKPWGQA K361
NUSAP1 (rat) under review -
K378-ub
EPHKGkLkPWGQSkE
0 1
NUSAP1 (human) EPHKGkLkPWGQSkE K378-ub
NUSAP1 iso2 (human) EPHKGKLKPWGQSKE K377
NUSAP1 (mouse) KPHKGKLKPWGQAKE K363
NUSAP1 (rat) NSTAGKLKPWGQAKE K312
K384-m1
LkPWGQSkENNyLNQ
0 1
NUSAP1 (human) LkPWGQSkENNyLNQ K384-m1
NUSAP1 iso2 (human) LKPWGQSKENNYLNQ K383
NUSAP1 (mouse) LKPWGQAKENNSLNE K369
NUSAP1 (rat) LKPWGQAKENNSLNE K318
Y388-p
GQSkENNyLNQHVNR
0 3
NUSAP1 (human) GQSkENNyLNQHVNR Y388-p
NUSAP1 iso2 (human) GQSKENNYLNQHVNR Y387
NUSAP1 (mouse) GQAKENNSLNERVSR S373
NUSAP1 (rat) GQAKENNSLNECVSR S322
K404-ub
NFYKKTYkQPHLQTk
0 1
NUSAP1 (human) NFYKKTYkQPHLQTk K404-ub
NUSAP1 iso2 (human) NFYKKTYKQPHLQTK K403
NUSAP1 (mouse) TFHRKTYKQPHLQTR K389
NUSAP1 (rat) TLHRKTYKQPPLQTR K338
K411-ac
kQPHLQTkEEQRKKR
Upstream
0 3
Treatment
  • MS275
NUSAP1 (human) kQPHLQTkEEQRKKR K411-ac
NUSAP1 iso2 (human) KQPHLQTKEEQRKKR K410
NUSAP1 (mouse) KQPHLQTREERWKRQ R396
NUSAP1 (rat) KQPPLQTREEQRKRH R345